Related Experiment Videos

Simultaneous occurrence of perimembranous glomerulonephritis and glomerular amyloidosis

Virchows Archiv. A, Pathological Anatomy and Histology
|July 26, 1978
PubMed

Insights

Penicillamine treatment for rheumatoid arthritis can lead to nephrotic syndrome. Renal biopsies revealed co-occurring perimembranous glomerulonephritis and amyloidosis as the cause.

Area of Science:

  • Nephrology
  • Rheumatology
  • Pathology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Penicillamine is a chelating agent used in treating RA.
  • Nephrotic syndrome is a kidney disorder characterized by heavy protein loss.

Observation:

  • Electron microscopy of renal biopsies from 3 RA patients treated with penicillamine was performed.
  • All patients developed nephrotic syndrome after discontinuing penicillamine.
  • Segmental perimembranous glomerulonephritis and glomerular renal amyloidosis were observed.

Findings:

  • The nephrotic syndrome was attributed to the simultaneous occurrence of perimembranous glomerulonephritis and renal amyloidosis.
  • Perimembranous glomerulonephritis with immune complex deposits was the primary cause in 2 cases.
  • Renal amyloidosis was the primary cause in 1 case.

Implications:

  • This study highlights potential renal complications of penicillamine therapy in RA patients.
  • Simultaneous glomerulonephritis and amyloidosis can cause nephrotic syndrome.
  • Understanding these co-existing pathologies is crucial for patient management.

Related Concept Videos